Matches in SemOpenAlex for { <https://semopenalex.org/work/W2766702403> ?p ?o ?g. }
- W2766702403 endingPage "591" @default.
- W2766702403 startingPage "585" @default.
- W2766702403 abstract "It is recommended to perform multiparametric magnetic resonance imaging (mpMRI) in the follow-up following focal therapy of prostate cancer (PCa).To determine the diagnostic accuracy of mpMRI to detect residual PCa following focal therapy with irreversible electroporation.Seventy-six patients with biopsy-proven localized PCa consented for primary irreversible electroporation between February 2013 and March 2016. Final analysis was performed on 50 patients that received follow-up mpMRI at 6 mo, serial prostate-specific antigen (PSA) testing, and transperineal template-mapping biopsies at 12 mo.Outfield regions of interest (ROI) were reported using PI-RADS version 2. A binary outcome (suspicious vs nonsuspicious) was given for the infield ablation zone. Sensitivity, specificity, positive predictive values, and negative predictive values were calculated for different definitions of significant PCa: (1) Gleason ≥4+3 or Gleason ≥3+3 with a maximum cancer core length ≥6mm, (2) Gleason ≥3+4 or Gleason ≥3+3 with a maximum cancer core length ≥4mm, for outfield and infield ROI. Multivariate linear regression analyses evaluated the additional value of nadir PSA.Sensitivity, specificity, positive predictive values, and negative predictive values of infield ROI was 43%, 86%, 33%, and 90% for definition 1 and 38%, 86%, 33%, and 88% for definition 2, respectively. For outfield ROI this was 33%, 82%, 20%, and 90% for definition 1 and 38%, 86%, 50%, and 80% for definition 2. PSA had no additional value in predicting residual significant PCa. Limitations include retrospective design, single reader, and low incidence of residual PCa.Our preliminary data suggest that mpMRI can rule out high-volume residual PCa. However, follow-up biopsies should still be performed to determine oncological control.Multiparametric magnetic resonance imaging is able to detect high-volume significant prostate cancer following focal therapy. Prostate biopsies are still required in the follow-up of focal therapy as (low-volume) significant prostate cancer is being missed by multiparametric magnetic resonance imaging." @default.
- W2766702403 created "2017-11-10" @default.
- W2766702403 creator A5005238316 @default.
- W2766702403 creator A5006262143 @default.
- W2766702403 creator A5006944238 @default.
- W2766702403 creator A5020534914 @default.
- W2766702403 creator A5020648785 @default.
- W2766702403 creator A5031681358 @default.
- W2766702403 creator A5035451634 @default.
- W2766702403 creator A5067765815 @default.
- W2766702403 creator A5078852863 @default.
- W2766702403 creator A5086098080 @default.
- W2766702403 creator A5090421656 @default.
- W2766702403 date "2019-07-01" @default.
- W2766702403 modified "2023-10-07" @default.
- W2766702403 title "Preliminary Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging to Detect Residual Prostate Cancer Following Focal Therapy with Irreversible Electroporation" @default.
- W2766702403 cites W1494521255 @default.
- W2766702403 cites W1830758076 @default.
- W2766702403 cites W1965809713 @default.
- W2766702403 cites W1985195438 @default.
- W2766702403 cites W2002327210 @default.
- W2766702403 cites W2061259677 @default.
- W2766702403 cites W2082328647 @default.
- W2766702403 cites W2120345934 @default.
- W2766702403 cites W2152991866 @default.
- W2766702403 cites W2265299097 @default.
- W2766702403 cites W2334235689 @default.
- W2766702403 cites W2336442715 @default.
- W2766702403 cites W2510720854 @default.
- W2766702403 cites W2520389576 @default.
- W2766702403 cites W2529080716 @default.
- W2766702403 cites W2601227959 @default.
- W2766702403 cites W4254021855 @default.
- W2766702403 doi "https://doi.org/10.1016/j.euf.2017.10.007" @default.
- W2766702403 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29102671" @default.
- W2766702403 hasPublicationYear "2019" @default.
- W2766702403 type Work @default.
- W2766702403 sameAs 2766702403 @default.
- W2766702403 citedByCount "22" @default.
- W2766702403 countsByYear W27667024032018 @default.
- W2766702403 countsByYear W27667024032019 @default.
- W2766702403 countsByYear W27667024032020 @default.
- W2766702403 countsByYear W27667024032021 @default.
- W2766702403 countsByYear W27667024032022 @default.
- W2766702403 countsByYear W27667024032023 @default.
- W2766702403 crossrefType "journal-article" @default.
- W2766702403 hasAuthorship W2766702403A5005238316 @default.
- W2766702403 hasAuthorship W2766702403A5006262143 @default.
- W2766702403 hasAuthorship W2766702403A5006944238 @default.
- W2766702403 hasAuthorship W2766702403A5020534914 @default.
- W2766702403 hasAuthorship W2766702403A5020648785 @default.
- W2766702403 hasAuthorship W2766702403A5031681358 @default.
- W2766702403 hasAuthorship W2766702403A5035451634 @default.
- W2766702403 hasAuthorship W2766702403A5067765815 @default.
- W2766702403 hasAuthorship W2766702403A5078852863 @default.
- W2766702403 hasAuthorship W2766702403A5086098080 @default.
- W2766702403 hasAuthorship W2766702403A5090421656 @default.
- W2766702403 hasBestOaLocation W27667024031 @default.
- W2766702403 hasConcept C104317684 @default.
- W2766702403 hasConcept C121608353 @default.
- W2766702403 hasConcept C126322002 @default.
- W2766702403 hasConcept C126838900 @default.
- W2766702403 hasConcept C143409427 @default.
- W2766702403 hasConcept C185592680 @default.
- W2766702403 hasConcept C186852380 @default.
- W2766702403 hasConcept C2775934546 @default.
- W2766702403 hasConcept C2776235491 @default.
- W2766702403 hasConcept C2778716261 @default.
- W2766702403 hasConcept C2780192828 @default.
- W2766702403 hasConcept C2781406297 @default.
- W2766702403 hasConcept C2989005 @default.
- W2766702403 hasConcept C3019719930 @default.
- W2766702403 hasConcept C53789813 @default.
- W2766702403 hasConcept C55493867 @default.
- W2766702403 hasConcept C71924100 @default.
- W2766702403 hasConceptScore W2766702403C104317684 @default.
- W2766702403 hasConceptScore W2766702403C121608353 @default.
- W2766702403 hasConceptScore W2766702403C126322002 @default.
- W2766702403 hasConceptScore W2766702403C126838900 @default.
- W2766702403 hasConceptScore W2766702403C143409427 @default.
- W2766702403 hasConceptScore W2766702403C185592680 @default.
- W2766702403 hasConceptScore W2766702403C186852380 @default.
- W2766702403 hasConceptScore W2766702403C2775934546 @default.
- W2766702403 hasConceptScore W2766702403C2776235491 @default.
- W2766702403 hasConceptScore W2766702403C2778716261 @default.
- W2766702403 hasConceptScore W2766702403C2780192828 @default.
- W2766702403 hasConceptScore W2766702403C2781406297 @default.
- W2766702403 hasConceptScore W2766702403C2989005 @default.
- W2766702403 hasConceptScore W2766702403C3019719930 @default.
- W2766702403 hasConceptScore W2766702403C53789813 @default.
- W2766702403 hasConceptScore W2766702403C55493867 @default.
- W2766702403 hasConceptScore W2766702403C71924100 @default.
- W2766702403 hasIssue "4" @default.
- W2766702403 hasLocation W27667024031 @default.
- W2766702403 hasLocation W27667024032 @default.
- W2766702403 hasOpenAccess W2766702403 @default.
- W2766702403 hasPrimaryLocation W27667024031 @default.
- W2766702403 hasRelatedWork W1562988833 @default.